Cryptolepis buchanani (Wax-Leaved Climber)

Cryptolepis buchanani (Wax-Leaved Climber)

Product Name: Криптолепсис Бьюкеннена, Cryptolepis buchanani, Buchanan-Schlangenpflanze, Criptolepis de Buchanan, Cryptolepis de Buchanan, كريبتوليبس بوكانان, คริปโตเลพิส บูคานานี

Synonyms: Криптолепис, Криптолепис кустарниковый, Бьюкеннанов кустарник; Cryptolepis, Indian Sarsaparilla, Wax-Leaved Climber, Buchanan's bush, Cryptolepis shrub; Kletterstrauch von Buchanan, Busch-Cryptolepis; criptólépis, arbusto de Buchanan; cryptolepis, arbuste de Buchanan; كريبتوليبس, شجيرة بوكانان; คริปโตเลพิส, ไม้พุ่มบูคานาน

Main Indications for Use of Cryptolepis buchanani: Infectious dermatoses of bacterial etiology, skin candidiasis, purulent wounds, ulcers of trophic and infectious nature, rheumatoid arthritis, chronic osteoarthritis, dyspepsia, gastric and duodenal ulcer, gastritis with reduced secretion, parasitic invasions, malaria, furunculosis, soft tissue abscesses, streptoderma, microbial eczema.

Use of Cryptolepis buchanani in Mixtures and Complexes: Infectious lesions of the upper respiratory tract, acute bronchitis, pneumonia, chronic pyelonephritis, viral hepatitis, herpetic infection, hypertrophic gastritis, ulcerative colitis, allergic vasculitis, psoriasis, type 2 diabetes mellitus, diabetic polyneuropathy, toxic neuropathy, post-infectious neuropathy, seborrheic dermatitis, systemic lupus erythematosus.

Pharmacological Properties of Cryptolepis buchanani: antimicrobial, antifungal, anti-inflammatory, antioxidant, antirheumatic, spasmolytic, hepatoprotective, antiparasitic, wound-healing, immunomodulatory, antimalarial.

Dosage of Pharmaceutical Forms — Cryptolepis buchanani

Powder — Cryptolepis buchanani

Indications (Powder): Infectious dermatoses of bacterial etiology, skin candidiasis, ulcers of trophic nature, furunculosis, osteoarthritis, rheumatoid arthritis, dyspepsia, parasitic invasions, purulent wounds, microbial eczema.

Standard Dosage (Powder): 1 g of powder three times a day after meals, washed down with warm water. Course duration — 14 days.

Enhanced Dosage (Powder): 1.5 g of powder three times a day, for acute bacterial skin inflammations, ulcers with a necrotic bottom, furunculosis, and parasitic infections with pronounced symptoms. Course duration — up to 10 days.

Maximum Dosage (Powder): 2 g of powder three times a day, exclusively when prescribed by a physician under outpatient supervision, for multiple infected wounds or chronic ulcers with signs of secondary infection.

Preventive Dosage (Powder): 0.5 g once daily for 10 days each month. Recommended for chronic recurrent furunculosis, impaired wound healing in patients with diabetes, and elderly patients with frequent skin inflammations.

Pediatric Dosage (Powder): From 7 years of age, with a body weight of at least 25 kg — 250 mg of powder twice daily. Under 7 years of age and in children with a body weight below 25 kg, use is not recommended. Gender does not affect the dosage.

Contraindications (Powder): Individual hypersensitivity, acute nephritis, severe forms of hepatopathies. Data on contraindications during pregnancy, lactation, and in childhood under 7 years of age have not been scientifically registered.

Side Effects (Powder): In case of overdose: nausea, metallic taste in the mouth, short-term gastric spasms. Cases of skin rash have been described when taking more than 6 g per day.

Adjustment for Patient Body Weight (Powder): For body weight below 60 kg — reduce each dose by 20%. For body weight over 90 kg — a dose increase of 10–15% is possible under monitoring of the patient's condition.

Preparation Method (Powder): Collected mature stems and roots are cleaned of bark, washed in running water, then dried at a temperature of 45 degrees Celsius for 48 hours. After complete drying, they are ground in a porcelain mortar or on a stone mill to a fine homogeneous powder. For 100 g of finished powder, about 350 g of fresh raw material are used.

Storage Conditions and Shelf Life (Powder): Store in an airtight glass container at a temperature of 15 to 25 degrees Celsius, in a dry, darkened place protected from sources of electromagnetic radiation. Shelf life — up to 12 months. After opening the package, use within 60 days.

Dry Extract — Cryptolepis buchanani

Indications (Dry Extract): Rheumatoid arthritis, chronic osteoarthritis, gastric ulcer, parasitic invasions, microbial eczema, purulent wounds, streptoderma, skin candidiasis, ankylosing spondylitis.

Standard Dosage (Dry Extract): 250 mg of dry extract (standardized for cryptolepsin) twice daily, 20 minutes before meals. Course — 14 days.

Enhanced Dosage (Dry Extract): 500 mg three times a day for acute inflammatory or parasitic lesions, and for ulcerative defects of the gastrointestinal tract in the exacerbation phase. Course — up to 10 days.

Maximum Dosage (Dry Extract): 1 g twice daily under strict medical supervision. Permissible for phlegmonous inflammations of soft tissues, multiple ulcers, and chronic recurrent infections.

Preventive Dosage (Dry Extract): 150 mg once daily for 10 days monthly. Suitable for patients with a predisposition to skin infections, rheumatic reactions, people over 60 years of age, as well as patients with diabetes mellitus.

Pediatric Dosage (Dry Extract): From 10 years of age, with a body weight from 35 kg — 100 mg once daily. Under 10 years of age, use of the extract is not recommended due to the absence of safety data.

Contraindications (Dry Extract): Individual intolerance, acute hepatopathies. No data on contraindications during pregnancy, lactation, and in children under 10 years of age have been scientifically registered.

Side Effects (Dry Extract): When the dose is exceeded, dry mouth, mild diarrhea, and a burning sensation in the epigastrium are possible. Side effects are reversible.

Adjustment for Patient Body Weight (Dry Extract): For body weight below 60 kg, the dose is reduced by 25%. For body weight above 90 kg, the dose is increased by 10–15%.

Preparation Method (Dry Extract): To prepare 100 g of dry extract, 1000 g of crushed raw material (stems and roots) are used. The raw material is poured with distilled water and infused for 6 hours. Then triple extraction is carried out at a temperature of 80 °C for 1.5 hours each. The combined aqueous extracts are filtered and evaporated at a temperature not exceeding 50 °C on a vacuum rotary evaporator to a thick state, after which they are dried in a drying chamber with a flow of dried air. The resulting extract is sifted and packaged in airtight containers.

Storage Conditions and Shelf Life (Dry Extract): Store in an airtight package in a dry, dark place at a temperature of 10 to 25 °C. Avoid exposure to direct light and EMI. Shelf life — 24 months. After opening, use within 45 days.

Alcohol-Based Tincture — Cryptolepis buchanani

Indications (Tincture): Rheumatoid arthritis, chronic osteoarthritis, ankylosing spondylitis, purulent inflammations of soft tissues, microbial eczema, malaria, parasitic invasions, ulcerative skin lesions.

Standard Dosage (Tincture): 15 drops of tincture per 20 ml of warm water twice daily, 30 minutes before meals. Course — 10–14 days.

Enhanced Dosage (Tincture): 20 drops per 20 ml of water 3 times a day for pronounced arthritic and parasitic processes. Course — up to 10 days.

Maximum Dosage (Tincture): 25 drops up to 4 times a day under medical supervision. Permitted only in acute stages of severe infectious processes (e.g., malaria, abscesses). Maximum 7 days.

Preventive Dosage (Tincture): 10 drops in 30 ml of water once daily for 7 days monthly. Indicated for chronic arthropathies, in elderly patients, with a predisposition to skin infections, as well as in individuals residing in malaria-endemic regions.

Pediatric Dosage (Tincture): From 12 years of age, with a body weight from 40 kg — 5–7 drops per 20 ml of water 1–2 times a day. Under 12 years of age, not recommended due to ethanol content.

Contraindications (Tincture): Alcoholism, epilepsy, active gastric ulcer, severe psychoneurological states. Data on contraindications during pregnancy, lactation, and in childhood under 12 years of age have not been scientifically registered.

Side Effects (Tincture): Irritation of the gastric mucosa, dizziness, increased peristalsis. Isolated cases of insomnia have been noted when taken in the evening.

Adjustment for Patient Body Weight (Tincture): For body weight below 60 kg, the dose is reduced by 20%. For body weight above 90 kg, an increase in the daily dose by 15% is possible.

Preparation Method (Tincture): 100 g of crushed dry raw material (stems and roots) are poured with 500 ml of 50% ethyl alcohol (organic origin, without denaturation). Infused in a tightly sealed glass container at a temperature of 20–22 °C in a dark place for 10 days. Shaken daily. Then the tincture is filtered through cotton cloth and poured into dark bottles.

Storage Conditions and Shelf Life (Tincture): Store in a tightly sealed glass container, in a dark, cool place at a temperature of 8 to 20 °C. Avoid exposure to sunlight and sources of EMI. Shelf life — up to 24 months. After opening, use within 60 days.

Oil Infusion — Cryptolepis buchanani

Indications (Oil Infusion): Rheumatoid arthritis, chronic osteoarthritis, myalgia, inflammatory skin diseases, furunculosis, microbial eczema, streptoderma, trophic ulcers, fungal skin lesions.

Standard Dosage (Oil Infusion): Externally: apply to the affected area twice daily in a thin layer without rubbing in. Course — 10–14 days.

Enhanced Dosage (Oil Infusion): Externally: apply 3 times a day with light rubbing for 5–7 minutes for pronounced joint pain, purulent wounds, inflamed ulcers, or pronounced eczema. Duration — up to 10 days.

Maximum Dosage (Oil Infusion): Up to 5 applications per day, no more than 20 ml per day, on limited skin areas (no more than 15% of body surface). Used under medical supervision for trophic ulcers, extensive microbial eczema, and acute arthritic attacks.

Preventive Dosage (Oil Infusion): Once daily in the evening, for 7–10 days, for the prevention of arthritis relapses, seasonal skin exacerbations, as well as in elderly patients and patients with diabetic skin. Apply to risk zones — elbows, knees, feet.

Pediatric Dosage (Oil Infusion): From 5 years: apply to small skin areas once daily, no more than 5 ml per day. If the child's weight is less than 20 kg — do not use. The child's gender is not a factor.

Contraindications (Oil Infusion): Individual intolerance, weeping dermatoses with hypersensitivity to vegetable oils. No contraindications during pregnancy and lactation have been scientifically registered; however, caution should be exercised when used on large skin areas.

Side Effects (Oil Infusion): Local irritation, skin hyperemia, burning sensation. In isolated patients, increased skin itching is possible in the exudative form of eczema.

Adjustment for Patient Body Weight (Oil Infusion): For patients with body weight below 60 kg, it is recommended to apply no more than 10 ml per day. For weight above 90 kg, a dosage increase up to 20 ml per day is permissible.

Preparation Method (Oil Infusion): 100 g of dry crushed raw material (stems and roots) are poured with 500 ml of organic first cold-pressed sesame oil. Infused in a dark glass container at a temperature of 35 °C for 7 days, shaking daily. Then the mixture is heated in a water bath at a temperature of 45 °C for 1 hour, squeezed, and filtered through cloth. The finished infusion is packaged into sterile glass bottles.

Storage Conditions and Shelf Life (Oil Infusion): Store in a dark, cool place at a temperature of 10 to 20 °C, away from sources of heat and EMI. Shelf life — 6 months. After opening, use within 30 days.

Vaginal Suppositories — Cryptolepis buchanani

Indications (Vaginal Suppositories): Vaginal candidiasis, bacterial vaginosis, mixed vaginal infections, chronic cervicitis, post-antibiotic dysbiotic flora, purulent-inflammatory processes in the cervix, recovery after surgical interventions in gynecology.

Standard Dosage (Vaginal Suppositories): 1 suppository at night, intravaginally, for 7 days. Insert in a lying position, before bedtime.

Enhanced Dosage (Vaginal Suppositories): 2 times a day — morning and night, for acute candidiasis or mixed bacterial-fungal infections. Course — up to 5 days, then according to the standard regimen.

Maximum Dosage (Vaginal Suppositories): 3 suppositories per day (every 8 hours) is permitted during the first 72 hours for acute purulent processes. Only under gynecologist supervision.

Preventive Dosage (Vaginal Suppositories): 1 suppository every other day for 10 days after completion of antibacterial treatment, in women with frequent episodes of thrush and bacterial vaginosis, as well as in premenopausal age. Courses are repeated every 2 months.

Pediatric Dosage (Vaginal Suppositories): Not recommended for use in children and adolescents under 18 years of age due to the absence of clinical data. Patient gender — female.

Contraindications (Vaginal Suppositories): Allergic reactions to plant components, acute bleeding from the genital tract, intolerance to cocoa butter or other fat bases. No contraindications during pregnancy and lactation have been scientifically registered; however, an individual medical approach is required during these periods.

Side Effects (Vaginal Suppositories): Burning, itching, local hyperemia of the mucosa. In rare cases — exacerbation of dysbiosis symptoms during the first application.

Adjustment for Patient Body Weight (Vaginal Suppositories): No adjustment is required — suppositories are applied locally and do not have a systemic effect dependent on body weight.

Preparation Method (Vaginal Suppositories): To prepare 100 g of vaginal suppositories, 20 g of dry Cryptolepis buchanani extract, 75 g of natural cocoa butter, and 5 g of beeswax are used. The butter is melted in a water bath to a temperature of 45 °C, beeswax is added, then the crushed extract is introduced with constant stirring. The resulting mass is poured into molds of 2 g each and cooled at a temperature of 5 °C until completely solidified.

Storage Conditions and Shelf Life (Vaginal Suppositories): Store in the refrigerator at a temperature of +2 to +8 °C, away from light and sources of electromagnetic field. Shelf life — 6 months. After opening the package, use within 10 days.

Rectal Suppositories — Cryptolepis buchanani

Indications (Rectal Suppositories): Parasitic invasions (including enterobiasis, ascariasis), hemorrhoids with signs of inflammation, anal fissures, chronic proctitis, purulent inflammations of the rectal mucosa, post-antibiotic dysbiotic microflora.

Standard Dosage (Rectal Suppositories): 1 suppository rectally before bedtime for 7 days. Insert deep into the rectum after natural evacuation.

Enhanced Dosage (Rectal Suppositories): 2 times a day (morning and evening), for pronounced inflammation, itching forms of parasitic invasions, and hemorrhoidal thrombosis. Course — 5–7 days.

Maximum Dosage (Rectal Suppositories): Up to 3 suppositories per day (every 8 hours) is permitted for 3 days for acute purulent proctitis and recurrent parasitosis, then switch to the standard regimen.

Preventive Dosage (Rectal Suppositories): 1 suppository every other day for 10 days every 3 months for chronic hemorrhoids, a tendency to constipation, as part of antiparasitic prophylaxis in children over 10 years of age and adults.

Pediatric Dosage (Rectal Suppositories): From 10 years of age, with a body weight from 30 kg — ½ suppository (divided lengthwise) once daily. Under 10 years of age, do not use. Gender does not matter.

Contraindications (Rectal Suppositories): Fresh rectal bleeding, acute fissures in the suppuration stage, hypersensitivity to base components. Data on contraindications during pregnancy and lactation are absent; use is not recommended without medical consultation.

Side Effects (Rectal Suppositories): Mild burning in the anorectal zone, frequent urges to defecate, transient diarrhea when the dosage is exceeded.

Adjustment for Patient Body Weight (Rectal Suppositories): For body weight up to 40 kg — ½ suppository per day. Over 90 kg — if necessary, the use of 2 suppositories per day under medical supervision is permissible.

Preparation Method (Rectal Suppositories): For 100 g of finished suppositories, 20 g of dry Cryptolepis buchanani extract, 75 g of cocoa butter, and 5 g of anhydrous lanolin are used. The butter and lanolin are melted in a water bath, the extract is added with constant stirring until uniform distribution. The mixture is poured into molds of 2 g each and cooled at +5 °C until solidified.

Storage Conditions and Shelf Life (Rectal Suppositories): Store in the refrigerator at a temperature of +2…+8 °C in a dark place, without exposure to EMI. Shelf life — 6 months. After opening, use within 7–10 days.

Nasal Drops — Cryptolepis buchanani

Indications (Nasal Drops): Acute rhinitis of bacterial etiology, chronic rhinosinusitis, purulent sinusitis, adenoiditis in adults, infectious-allergic rhinitis.

Standard Dosage (Nasal Drops): 2 drops into each nostril 3 times a day. Course — 5–7 days.

Enhanced Dosage (Nasal Drops): 3 drops into each nostril 4 times a day for abundant purulent discharge and mucosal edema. Maximum — 5 consecutive days.

Maximum Dosage (Nasal Drops): 4 drops 5 times a day, no more than 3 consecutive days. Applicable only for purulent forms of sinusitis under medical supervision.

Preventive Dosage (Nasal Drops): 1 drop into each nostril once daily for 5 days monthly during periods of seasonal morbidity. Indicated for chronic rhinitis, patients with weakened immunity, school-age children, and the elderly.

Pediatric Dosage (Nasal Drops): From 7 years: 1 drop twice daily, with a weight from 25 kg. Under 7 years — do not use due to the risk of mucosal irritation. Gender does not affect the dose.

Contraindications (Nasal Drops): Hypersensitivity, a tendency to nasal bleeding, acute allergic rhinitis. Data on contraindications during pregnancy and lactation are absent; use according to indications is possible.

Side Effects (Nasal Drops): Short-term burning in the nose, increased sneezing, a feeling of congestion. In case of overdose — abundant serous discharge.

Adjustment for Patient Body Weight (Nasal Drops): For patients with body weight less than 40 kg — no more than 2 drops per dose. For patients over 90 kg, an increase in daily frequency of use up to 5 times a day is possible.

Preparation Method (Nasal Drops): To prepare 100 ml of solution, take 2 g of dry Cryptolepis buchanani extract, dissolve in 100 ml of physiological sodium chloride solution (0.9%) with the addition of 1 ml of glycerin (natural vegetable origin). The solution is stirred until complete dissolution of the extract, filtered through a sterile paper filter, and poured into droppers. Recommended pH of the solution — 5.5–6.0.

Storage Conditions and Shelf Life (Nasal Drops): Store at a temperature of +4…+8 °C in an airtight dark glass bottle. Avoid exposure to light and magnetic fields. Shelf life — up to 30 days. After opening, use within 10 days.

Ear Drops — Cryptolepis buchanani

Indications (Ear Drops): Acute external otitis, bacterial otitis media, eczema of the external auditory canal, fungal ear infection (otomycosis), complicated perichondritis, inflammation of the auricle.

Standard Dosage (Ear Drops): 2 drops into the external auditory canal 3 times a day. After instillation, it is recommended to lie for 5 minutes on the opposite side. Course — 7 days.

Enhanced Dosage (Ear Drops): 3 drops 4 times a day for pronounced edema and purulent discharge. May be used in combination with turundas. Duration — up to 5 days.

Maximum Dosage (Ear Drops): 4 drops 5 times a day for acute purulent and fungal inflammations, exclusively under medical supervision. Maximum — 3 days, then switch to the standard regimen.

Preventive Dosage (Ear Drops): 1 drop into each ear once daily for 5 days after water procedures, during the recovery period after otitis, in patients with eczematous skin of the auditory canal or a tendency to fungal infections.

Pediatric Dosage (Ear Drops): From 6 years of age, with a body weight from 20 kg — 1 drop twice daily. Under 6 years — not recommended. The child's gender is not a factor.

Contraindications (Ear Drops): Perforation of the eardrum, presence of foreign bodies in the ear, allergy to the phyto-composition. No data on contraindications during pregnancy and lactation have been registered.

Side Effects (Ear Drops): Rarely — local burning, hyperemia of the auditory canal, increased itching. Complaints of short-term ear fullness after instillation are possible.

Adjustment for Patient Body Weight (Ear Drops): For patients with body weight up to 40 kg — no more than 2 drops twice daily. Over 90 kg — an increase up to 4 drops 4 times a day is permissible, provided the eardrum is intact.

Preparation Method (Ear Drops): 100 ml of organic sesame oil are heated to 40 °C, 2 g of dry Cryptolepis buchanani extract and 0.5 g of natural beeswax are added. The mixture is infused at 45 °C for 4 hours in a water bath, then filtered through cloth. Packaged into sterile glass dropper bottles.

Storage Conditions and Shelf Life (Ear Drops): Store at a temperature of +5 to +25 °C in a dark place, away from sources of heat, moisture, and EMI. Shelf life — 6 months. After opening, use within 14 days.

Ointment/Cream — Cryptolepis buchanani

Indications (Ointment/Cream): Infectious dermatoses of bacterial and fungal etiology, eczematous skin lesions, furunculosis, streptoderma, trophic ulcers, psoriasides, skin inflammations in arthritic conditions.

Standard Dosage (Ointment/Cream): Apply in a thin layer to affected skin areas twice daily. Course — 10–14 days, depending on the severity of the condition.

Enhanced Dosage (Ointment/Cream): Apply 3 times a day for pronounced inflammatory dermatoses, purulent eruptions, and eczemas with serous discharge. Course — up to 10 days, then switch to the standard regimen.

Maximum Dosage (Ointment/Cream): Apply 4 times a day (every ~6 hours), but no more than 30 g per day over the entire body area. Only under medical supervision for extensive skin lesions or mixed infection.

Preventive Dosage (Ointment/Cream): Apply once daily before bedtime to skin areas prone to relapses — for example, elbow and knee flexures, zones over joints — in a course of 7 days monthly; especially indicated for patients with atopic dermatitis in remission, diabetes, and psoriasis with mild activity.

Pediatric Dosage (Ointment/Cream): From 3 years — apply 1–2 times a day in a thin layer. Body weight from 15 kg. Not recommended under 3 years. The child's gender does not affect.

Contraindications (Ointment/Cream): Individual intolerance, weeping dermatoses with hypersensitivity to the components. No data on contraindications during pregnancy and lactation have been registered; external use on limited areas is permissible.

Side Effects (Ointment/Cream): Rare — local irritation, burning on application. With excessive use, contact dermatitis is possible.

Adjustment for Patient Body Weight (Ointment/Cream): For mild forms (weight below 60 kg), it is sufficient to apply thinly — no more than 15 g per day. For patients with body weight above 90 kg with extensive lesions, up to 30 g of ointment per day is permissible.

Preparation Method (Ointment/Cream): Per 100 g of finished ointment: 10 g of dry Cryptolepis buchanani extract; 30 g of shea butter (organic); 30 g of cocoa butter; 30 g of natural beeswax. The oils are melted in a water bath at +60 °C, wax is added, and stirred until homogeneous. Remove from heat, cool to +45 °C, introduce the extract, and stir thoroughly. Pour into glass jars and cool to room temperature.

Storage Conditions and Shelf Life (Ointment/Cream): Store in glass jars at a temperature of +10…+25 °C, in the shade, protected from EMI. Shelf life — 12 months. After opening — in a dry place no more than 90 days.

Toxicity and Biosafety of Cryptolepis buchanani

Data on the toxicological safety of Cryptolepis buchanani indicate a satisfactory profile with oral and external use. A study on rats using the methanol extract showed that the lethal dose (LD50) with oral administration exceeds 2000 mg/kg body weight, which indicates low acute toxicity of the substance. No lethal outcomes, pronounced changes in behavior, body weight, or pathomorphological changes in internal organs were observed in the animals. In addition, with prolonged application to the skin as part of ointments and oils, signs of skin sensitization were not registered. Immunotoxic, hepato-, or neurotoxic effects at doses used in traditional medicine have not been noted. Thus, Cryptolepis buchanani can be considered biologically safe when used within the therapeutic range.

Reference: https://www.thepharmajournal.c...

Pharmacodynamics — Cryptolepis buchanani

Extracts of Cryptolepis buchanani exhibit pronounced anti-inflammatory activity in various preclinical models, including suppression of edema, inhibition of eicosanoid synthesis, and reduction of the release of pro-inflammatory cytokines (e.g., TNF-α) from monocyte/macrophage cells ijpsr.com+11pubmed.ncbi.nlm.nih.gov+11onlinelibrary.wiley.com+11. In preclinical studies in rats, the methanol extract reduced the pain reaction in the acetic acid–induced writhing model, which confirms the analgesic effect pubmed.ncbi.nlm.nih.gov+1researchgate.net+1. The extract also demonstrates a chondroprotective effect: in cultures of porcine cartilage discs, a decrease in the degradation of sulfated glycosaminoglycans and inhibition of matrix metalloproteinase-2 activity were observed tis.wu.ac.th+6pubmed.ncbi.nlm.nih.gov+6onlinelibrary.wiley.com+6. These effects indicate modulation of the inflammatory response at the level of the cyclooxygenase pathway, excessive NO production, and MMP activity, as well as stabilization of the extracellular matrix. Antioxidant activity was noted in antioxidant tests, as well as in hepatoprotection in a model of acetaminophen intoxication, which suggests a mechanism through a reduction in cellular oxidative stress. In addition, immunomodulatory properties are revealed: a 95% ethanol root extract promoted stimulation of immune activity in vivo onlinelibrary.wiley.com+1sciencedirect.com+1. Thus, the pharmacodynamic profile of C. buchanani includes anti-inflammatory, analgesic, chondroprotective, antioxidant, and immunomodulatory activity, realized at both systemic and local levels.

References: researchgate.net, pubmed.ncbi.nlm.nih.gov, ijpsr.com.

Pharmacokinetics — Cryptolepis buchanani

Information on the pharmacokinetics of Cryptolepis buchanani is limited; therefore, generalized properties of the contained alkaloids and polyphenols are used. With oral administration, extracts undergo partial absorption through the gastrointestinal tract; bacterial microflora can metabolize flavonoid and phenolic components, improving their bioavailability. Systemic distribution is assumed in tissues involved in inflammation, including joints, liver, and skin, in connection with the anticatabolic and chondroprotective activity identified in tissue cultures. A significant portion of metabolites is likely subjected to hepatic conversion (phase I and II reactions) with subsequent excretion through bile and kidneys. With transdermal, rectal, or vaginal administration, active substances provide a local therapeutic concentration without significant systemic absorption. The urinary and biliary fractions of metabolites vary depending on the chemical class: polar derivatives of phenols are predominantly excreted in urine, while more lipophilic residues — with bile. Limited data indicate the absence of cumulation with standard courses, while metabolism and excretion occur within 24–48 hours. Additional studies are needed to determine pharmacokinetic parameters, including interindividual variability and therapeutic index, especially after sublingual and mucosal administration.

Mechanisms of Action and Scientific Rationale — Cryptolepis buchanani

Botanical extracts of Cryptolepis buchanani contain alkaloids, flavonoids, terpenes, phenols, and protein enzymes (cryptolepain) possessing various mechanisms of action. Alkaloids such as buchananine and sarverogenin derivatives bind cyclooxygenase and lipoxygenase, reducing the production of prostaglandins and leukotrienes, thereby reducing inflammation and pain pubmed.ncbi.nlm.nih.gov+11researchgate.net+11researchgate.net+11. Phenolic compounds (coumarin components, isoscopoletin) also inhibit NO synthase and cytokine levels, in particular TNF-α and IL-1β, as proven in vitro on RAW 264.7 and THP-1 models researchgate.net. In addition, the chondroprotective effect is realized through suppression of metalloproteinase-2, which prevents destruction of the extracellular matrix and cartilage degradation. The alkaloid cryptolepain, as a protease enzyme, participates in the suppression of inflammatory enzymes and proteolytic degradation of tissues. The antioxidant activity of phenols and flavonoids reduces oxidative stress, which delegates the NF-κB and MAPK pathways. In addition, in vivo stimulation of immune cells — macrophages and monocytes — is demonstrated, which indicates an immunostimulating effect, confirmed in vivo in mice and rats. These mechanisms of action combine enzymatic, signaling, and cellular levels, providing a broad therapeutic potential.

Synergy — Cryptolepis buchanani

Scientific studies show that extracts of Cryptolepis buchanani enhance pharmacodynamic effects in combination with other bioactive substances. In vitro, an additive and potentiating interaction with other anti-inflammatory phyto-compounds, such as flavonoids and phenolic acids, is observed due to joint inhibition of COX and NO synthase. Similarly, the combination of the extract with antioxidant agents enhances the ability to reduce cellular oxidative stress due to synergistic neutralization of ROS and support of antioxidant cascades. In an in vivo hypothesis, synergy with known chondroprotectors improves cartilage tissue regeneration. Synergistic effects with immunostimulating phyto-components are also indicated, which enhances macrophage activity and cytokine regulation. These interactions have been confirmed by preclinical studies, where the combined action demonstrated a more pronounced anti-inflammatory and chondroprotective effect than the individual components of the extract.